(Q39148665)

English

Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.

scientific article published on 24 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Rong Bu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Azhar R Hussain

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Khadija A S Al-Obaisi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Maqbool Ahmed

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Khawla S Al-Kuraya

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

24 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

55

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

415-424

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23697845%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Stromal gene signatures in large-B-cell lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Prostate stem cell antigen is overexpressed in prostate cancer metastases

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

No one can whistle a symphony alone - how different ubiquitin linkages cooperate to orchestrate NF-κB activity

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Defining the geometry of the two-component proteasome degron

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

The ubiquitin-proteasome proteolytic pathway

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

IkappaB kinase complexes: gateways to NF-kappaB activation and transcription

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

NF-kappaB and IKK as therapeutic targets in cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

NF-kappaB and cancer: mechanisms and targets

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

NF-kappaB and cancer-identifying targets and mechanisms

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Inhibition of phosphatidylinositol 3'-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.806799

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39148665&oldid=1451004516"